HRSA is evaluating drugmakers' 340B contract pharmacy crackdowns

by on

HRSA is deciding whether to impose penalties on drugmakers that restrict the availability of 340B discounts.

HRSA is deciding whether to impose penalties on drugmakers that restrict the availability of 340B discounts.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: